A European contraceptive pill that works as a five-day alternative to the “morning after” pill may be coming to the U.S.‘s shores, but a thorny debate around the drug’s use and its chemical relation to the RU-486 abortion pill may have influence on the FDA’s endorsement. The FDA is staged to examine the risks of the new drug next week, but arguments are already heated as sides debate issues around when life begins and the rights of women to control their own bodies. —JCL The Washington Post: A French drug company is hoping to offer American women something their European counterparts already have: a pill that works long after “the morning after.” The drug, dubbed ella, would be sold as a contraceptive—one that could prevent pregnancy for as many as five days following unprotected sex. But the new drug is a close chemical relative of the abortion pill RU-486, raising the possibility that it could theoretically be used to induce abortion by making the womb inhospitable for an embryo. The controversy sparked by that ambiguity will force a panel of federal advisers scheduled to consider endorsing the drug next week to grapple with a host of thorny issues. The last time the Food and Drug Administration vetted an emergency contraceptive—Plan B, the so-called morning-after pill—the decision was mired in debate over such fundamental questions as when life begins and the distinction between preventing and terminating a pregnancy. Ella is raising many of those same politically charged questions—but more sharply, testing the Obama administration’s pledge to keep ideology from influencing scientific decisions. Read more Related Entries June 9, 2010 NBA Leads Sports in Diversity June 7, 2010 The Christian Fascists Are Growing Stronger
Read more here:
The Five-Morning After Pill?
